Zurich: The Swiss Agency for Therapeutic Products, swismedic Approved the use of Friday pfizer Vaccines for children aged 5-11 years.
“SwissMedic has carefully examined all data submitted with the Application for an Indication Extension for a Covid-19 Vaccine from Pfizer/BioNTech (Comirnati®). Clinical trial results suggest that the vaccine is effective in this age group.” is safe and effective … thus making it possible to vaccinate against the new coronavirus (SARS-CoV-2) in accordance with the federal government’s updated vaccination recommendations for children 5 years of age and older,” SwissMedic said in a statement on its website. said in.
The agency said that a study of more than 1,500 participants showed that the vaccine provides almost complete protection against COVID-19 in children aged 5-11. The agency said side effects include pain or fatigue at the injection site, sometimes Headache, pain in the limbs and fever.
According to the latest figures, 66 percent of Swiss citizens have been fully vaccinated against COVID-19.
“SwissMedic has carefully examined all data submitted with the Application for an Indication Extension for a Covid-19 Vaccine from Pfizer/BioNTech (Comirnati®). Clinical trial results suggest that the vaccine is effective in this age group.” is safe and effective … thus making it possible to vaccinate against the new coronavirus (SARS-CoV-2) in accordance with the federal government’s updated vaccination recommendations for children 5 years of age and older,” SwissMedic said in a statement on its website. said in.
The agency said that a study of more than 1,500 participants showed that the vaccine provides almost complete protection against COVID-19 in children aged 5-11. The agency said side effects include pain or fatigue at the injection site, sometimes Headache, pain in the limbs and fever.
According to the latest figures, 66 percent of Swiss citizens have been fully vaccinated against COVID-19.
,